Tarsus Pharmaceuticals, Inc. (TARS) — Net Income

Annual figures by fiscal year, from SEC filings.

2018: -$1.32M2019: -$4.67M2020: -$26.81M2021: -$13.83M2022: -$62.09M2023: -$135.89M2024: -$115.55M2025: -$66.42M-$66.42M
2018Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$66.42M+42.5%
2024-$115.55M+15.0%
2023-$135.89M-118.9%
2022-$62.09M-349.1%
2021-$13.83M+48.4%
2020-$26.81M-474.1%
2019-$4.67M-254.1%
2018-$1.32M